piribedil has been researched along with Syndrome in 3 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
Syndrome: A characteristic symptom complex.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Truy, E | 1 |
Veuillet, E | 1 |
Collet, L | 1 |
Morgon, A | 1 |
Shopsin, B | 1 |
Gershon, S | 1 |
Frediani, F | 1 |
Lamperti, E | 1 |
Avella, F | 1 |
Boiardi, A | 1 |
Graziussi, G | 1 |
Bussone, G | 1 |
3 other studies available for piribedil and Syndrome
Article | Year |
---|---|
Characteristics of transient otoacoustic emissions in patients with sudden idiopathic hearing loss.
Topics: Acute Disease; Adolescent; Adult; Aftercare; Aged; Audiometry, Pure-Tone; Cochlea; Drug Therapy, Com | 1993 |
Dopamine receptor stimulation in the treatment of depression: piribedil (ET-495).
Topics: Adjustment Disorders; Adult; Aged; Amphetamines; Anger; Antidepressive Agents; Bipolar Disorder; Bro | 1978 |
[Piribedil test in cephalalgic syndromes. Diagnostic and therapeutic usefulness].
Topics: Adolescent; Adult; Female; Headache; Humans; Male; Middle Aged; Migraine Disorders; Piperazines; Pir | 1987 |